NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
NovelStem International Max Drawdown (5Y) : 97.80% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 97.80% |
| June 30, 2026 | 97.80% |
| May 31, 2026 | 97.80% |
| April 30, 2026 | 97.80% |
| March 31, 2026 | 97.80% |
| February 28, 2026 | 97.80% |
| January 31, 2026 | 97.80% |
| December 31, 2025 | 97.80% |
| November 30, 2025 | 97.80% |
| October 31, 2025 | 97.80% |
| September 30, 2025 | 97.80% |
| August 31, 2025 | 97.80% |
| July 31, 2025 | 97.80% |
| June 30, 2025 | 97.80% |
| May 31, 2025 | 97.80% |
| April 30, 2025 | 97.80% |
| March 31, 2025 | 97.80% |
| February 28, 2025 | 97.80% |
| January 31, 2025 | 97.80% |
| December 31, 2024 | 97.77% |
| November 30, 2024 | 97.11% |
| October 31, 2024 | 97.11% |
| September 30, 2024 | 88.00% |
| August 31, 2024 | 82.86% |
| July 31, 2024 | 82.86% |
| Date | Value |
|---|---|
| June 30, 2024 | 82.86% |
| May 31, 2024 | 82.86% |
| April 30, 2024 | 82.86% |
| March 31, 2024 | 82.83% |
| February 29, 2024 | 82.83% |
| January 31, 2024 | 82.83% |
| December 31, 2023 | 82.83% |
| November 30, 2023 | 76.91% |
| October 31, 2023 | 69.46% |
| September 30, 2023 | 69.46% |
| August 31, 2023 | 69.46% |
| July 31, 2023 | 69.46% |
| June 30, 2023 | 69.46% |
| May 31, 2023 | 69.46% |
| April 30, 2023 | 69.46% |
| March 31, 2023 | 69.46% |
| February 28, 2023 | 69.46% |
| January 31, 2023 | 69.46% |
| December 31, 2022 | 69.46% |
| November 30, 2022 | 69.46% |
| October 31, 2022 | 69.46% |
| September 30, 2022 | 69.46% |
| August 31, 2022 | 69.46% |
| July 31, 2022 | 69.46% |
| June 30, 2022 | 69.46% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 43.45% |
| Summit Therapeutics, Inc. | 95.40% |
| Kezar Life Sciences, Inc. | 98.04% |
| Protara Therapeutics, Inc. | 99.25% |
| Clene, Inc. | 99.27% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.05 |
| Beta (5Y) | 2.429 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 135.0% |
| Historical Sharpe Ratio (5Y) | -0.3755 |
| Historical Sortino (5Y) | -0.9262 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.22% |